Specialty pharmaceuticals have exploded into the modern healthcare scene, and with one-third of growth stemming from hospital or health system-owned specialty pharmacies, awareness of specialty drug approvals and the pipeline is increasingly important.
Between news headlines and social media influencers raving about their weight loss, it appears semaglutide may be the miracle weight loss drug the world’s been waiting for. But should the healthcare community be so eager to adopt its use in pediatrics?
Steve Kennedy offers five questions about start up and operational considerations healthcare organizations should ask before launching their own home infusion and ambulatory infusion suite.
Given the incredible amounts of time and money invested in the specialty pharmacy market, it is important for key stakeholders to understand what medications are classified as specialty.
Come Jan. 31, Humira (adalimumab) will lose its exclusivity, opening the door for the eight approved adalimumab biosimilars to come to market by the end of 2023, which makes now a great time to discuss the differences between these biosimilar products.
The administration of infused drugs in the outpatient setting has traditionally been provided to patients in hospital-based and provider-based outpatient centers.
With the pharmacy resident recruiting season right around the corner, Tony Huke provides five tips to help you choose the best candidates for your program.
Drug Shortage Stewardship, a new concept that proposes a demand-side national approach, could be another tools to use when faced with the ever-present challenge of drug shortages.
Biosimilars are a hot topic in pharmacy right now, but will they really have an impact on the pharmaceutical industry? Senior Principal of Pharmacy Solutions Steven Lucio answers this question and more.
Some of the activities we enjoy so much during the summer can also put us at an increased risk of contracting tetanus. That’s why it’s important to be sure your tetanus vaccine is up to date.
After more than two years of grappling with a global pandemic, Americans are transitioning back into society with more and more people returning to work.
Four strategies tohelp manage the increased indicated uses and expenses for checkpoint inhibitors, a type of immunotherapy that blocks checkpoint proteins and helps stop the spread of cancer.
Specialty pharmaceuticals continue to dominate drug approvals and purchasing. And while many hospitals operate a specialty pharmacy, there’s still room for growth. Here’s five questions to ask when considering if a specialty pharmacy is right for your hosp...
As we move into the 2021–22 influenza season with a surge in COVID-19, vaccination against both viruses will be critical. Despite a good track record for flu vaccines, we can and must do better. As a health care provider, you have a unique opportunity to l...
Now that the federal government is recommending that many COVID-vaccinated Americans receive booster shots starting this fall, it’s important to know what a “booster” is and how it differs from a “third dose”. As information is being reported in the media ...
Mark Twain once said, “the report of my death was an exaggeration.” And throughout history, that statement was misquoted many times by those wanting to embellish a misjudged outcome. Given recent news reports of the closing of some hospital retail pharmaci...
Cyberattacks are at an all-time high, with health care consistently in the top five industries targeted by cyber criminals. Because health system pharmacies rely heavily on networks, software and electronic processes, they have wide exposure to these cyber...
Cyber intrusions continue to plague health care organizations and the impact has been heightened during the COVID-19 pandemic as resources and personnel are stretched thin and cyber attackers take advantage of increased vulnerabilities. As we move through ...
A cheer went up among Vizient and our members last year when HHS announced the termination of the FDA’s Unapproved Drugs Initiative to curb rising drug costs. Our analysis found that ending the program could protect the U.S. health care system from an addi...
One of the more recent advancements in pharmaceuticals has been transformative to the management of disease is the discovery and utilization of “monoclonal antibodies” (mAb). Its impact cannot be overstated. Learn more about how mAbs are also playing criti...
The drum beat for managing the COVID-19 pandemic from public health leaders continues to be test, test, test. Before investing in new technology, there are several considerations that chief financial officers should consider.